Skip to main content

Peer Review reports

From: Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy

Original Submission
13 Dec 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Author responded Author comments
Resubmission - Version 7
Submitted Manuscript version 7
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Author responded Author comments
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
19 May 2015 Editorially accepted
19 Jun 2015 Article published 10.1186/s12894-015-0040-7

You can find further information about peer review here.

Back to article page